Sunnybrook Research Institute
James Carlyle PhD
Scientist Phone: 416-480-6100, ext. 3382
Administrative Assistant: Meredith Maloney Education:
Appointments and Affiliations:
Research Focus:
Research Summary: The innate immune system represents a front line of defense against neoplasms, infectious disease and other pathogenic conditions. Natural killer (NK) cells are innate immune lymphocytes that play a key role in innate immune surveillance. NK cells can detect and destroy cancer cells, cells infected with bacteria and viruses, tissue transplants and other target cells. Understanding how NK cells mediate target cell recognition at the molecular level is a fundamental question of NK cell biology. Intrinsic to this understanding is a knowledge of how the mature NK cell repertoire is generated and shaped during NK cell development, how NK cells use surface receptors to sense what is harmless or dangerous and how receptor–ligand interactions assist NK cells in the decision to ignore or kill a potential target cell. Dr. Carlyle studies the role of NK cells in self–nonself discrimination by the innate immune system. NK cell biology is central to cancer immunology in three ways:
In addition, NK cell biology impacts pure infectious disease research, as NK cells play an important early role in the immune response to foreign pathogens, especially viruses and intracellular bacteria. In fact, many pathogens have evolved intricate means of subverting NK recognition and innate immunity. Finally, insight into the role of NK cells in self–nonself discrimination can be gleaned from genetic studies involving models of allo/xeno-transplantation. To date, Dr. Carlyle has outlined roles for MHC-dependent (Ly49:MHC I) and MHC-independent (NKR-P1B:Clr-b) interactions in fighting cancer and infectious disease. He is currently studying the structure, function and control of NK receptor and ligand expression, how pathogens can evade detection by NK cells and how NK recognition impacts rejection of bone marrow transplants. This knowledge could lead to therapies in cancer treatment, control of infectious disease, transplantation biology and perhaps autoimmunity. Selected Publications: See current publications list at PubMed Related News and Stories:
Related Links: | ||||||||||||||


